Showing 61 - 80 results of 472 for search '"positron"', query time: 0.07s Refine Results
  1. 61

    Scientific explanation of e+ and Weyl fermion for injecting semiconductor devices by Arwa Saud Abbas

    Published 2025-01-01
    Subjects: “…positron and electron beams…”
    Get full text
    Article
  2. 62

    Usefulness of Whole-Body Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Patients with Neurofibromatosis Type 1: A Systematic Review by Giorgio Treglia, Silvia Taralli, Francesco Bertagna, Marco Salsano, Barbara Muoio, Pierluigi Novellis, Maria Letizia Vita, Fabio Maggi, Alessandro Giordano

    Published 2012-01-01
    “…To systematically review the role of positron emission tomography (PET) with fluorine-18-fluorodeoxyglucose (FDG) in patients with neurofibromatosis type 1 (NF1). …”
    Get full text
    Article
  3. 63
  4. 64

    Imaging of Myocardial Ischemia–Reperfusion Injury Using Sodium [F]Fluoride Positron Emission Tomography/Computed Tomography in Rats and Humans by Hongyoon Choi MD, PhD, Jeong Hee Han PhD, Sue Yeon Lim MS, Inki Lee MD, Young-Seok Cho MD, PhD, Eun Ju Chun MD, PhD, Won Woo Lee MD, PhD

    Published 2017-04-01
    “…Positron emission tomography (PET)/computed tomography (CT) using sodium [ 18 F]fluoride (Na[ 18 F]F) has been proven to be a promising hot-spot imaging modality for myocardial infarction (MI). …”
    Get full text
    Article
  5. 65
  6. 66

    Utility of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan in Inflammatory Myopathies: Case Report and Literature Review by Juan Pablo Rivas-de Noriega, Javier Andrés Galnares-Olalde, Javier Zúñiga-Varga, Juan Pablo Herrera-Félix, Marco Antonio Alegría-Loyola, Alonso Turrent-Carriles

    Published 2018-01-01
    “…The utility of [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) scan is increasing for the complementary diagnosis of myopathies. …”
    Get full text
    Article
  7. 67
  8. 68

    Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging Data to Constrain a Positron Emission Tomography Kinetic Model: Theory and Simulations by Jacob U. Fluckiger, Xia Li, Jennifer G. Whisenant, Todd E. Peterson, John C. Gore, Thomas E. Yankeelov

    Published 2013-01-01
    “…We show how dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data can constrain a compartmental model for analyzing dynamic positron emission tomography (PET) data. We first develop the theory that enables the use of DCE-MRI data to separate whole tissue time activity curves (TACs) available from dynamic PET data into individual TACs associated with the blood space, the extravascular-extracellular space (EES), and the extravascular-intracellular space (EIS). …”
    Get full text
    Article
  9. 69

    Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography by Walter Koch, Christoph J. Auernhammer, Julia Geisler, Christine Spitzweg, Clemens C. Cyran, Harun Ilhan, Peter Bartenstein, Alexander R. Haug

    Published 2014-06-01
    “…We investigated the use of Ga-68-DOTA-Tyr 3 -octreotate (Ga-68-DOTA-TATE) positron emission tomography (PET) and standardized uptake values (SUVs) to predict the effectiveness of treatment with the somatostatin analogue octreotide acetate (Sandostatin LAR) in patients with neuroendocrine tumors (NETs). …”
    Get full text
    Article
  10. 70

    Detection of Apoptotic Cells in a Rabbit Model with Atherosclerosis-Like Lesions Using the Positron Emission Tomography Radiotracer [F]ML-10 by Fabien Hyafil, Alexy Tran-Dinh, Samuel Burg, Sébastien Leygnac, Liliane Louedec, Milan Milliner, Rana Ben Azzouna, Ayelet Reshef, Miri Ben Ami, Olivier Meilhac, Dominique Le Guludec

    Published 2015-08-01
    “…[ 18 F]ML-10 (2-(5-fluoro-pentyl)-2-methylmalonic acid) is a positron emission tomography (PET) radiotracer that accumulates in cells presenting apoptosis-specific membrane alterations. …”
    Get full text
    Article
  11. 71
  12. 72
  13. 73

    Synthesis of Poly[APMA]-DOTA-Cu Conjugates for Interventional Radionuclide Therapy of Prostate Cancer: Assessment of Intratumoral Retention by Micro–Positron Emission Tomography by Jianchao Yuan, Yezi You, Xin Lu, Otto Muzik, David Oupicky, Fangyu Peng

    Published 2007-01-01
    “…Prolonged retention of poly[APMA]-DOTA- 64 Cu conjugates within the tumor tissues was demonstrated by micro–positron emission tomography at 24 hours following intra-tumoral injection of the conjugates to human prostate xenografts in mice. …”
    Get full text
    Article
  14. 74

    Evaluation of [Cu]Cu-DOTA and [Cu]Cu-CB-TE2A Chelates for Targeted Positron Emission Tomography with an αβ-Specific Peptide by Sven H. Hausner, David L. Kukis, M. Karen J. Gagnon, Catherine E. Stanecki, Riccardo Ferdani, John F. Marshall, Carolyn J. Anderson, Julie L. Sutcliffe

    Published 2009-03-01
    “…The compounds were evaluated in vitro by enzyme-linked immunosorbent assay (against the integrin α v β 6 and the closely related integrin α v β 6 ) and by cell labeling (α v β 6 -positive DX3puroβ6/α v β 6 -negative DX3puro) and in vivo using micro-positron emission tomography in a mouse model bearing paired DX3puroβ6/Dx3puro xenografts. …”
    Get full text
    Article
  15. 75

    C-Methionine Positron Emission Tomographic Imaging of Biologic Activity of a Recurrent Glioblastoma Treated with Stereotaxy-Guided Laser-Induced Interstitial Thermotherapy by Norbert Galldiks, Wernholt von Tempelhoff, Deniz Kahraman, Lutz W. Kracht, Stefan Vollmar, Gereon R. Fink, Michael Schroeter, Roland Goldbrunner, Matthias Schmidt, Mohammad Maarouf

    Published 2012-07-01
    “…We monitored the metabolic effects of stereotaxy-guided LITT in a patient with a recurrent GBM using amino acid positron emission tomography (PET). Serial 11 C-methyl-L-methionine positron emission tomography (MET-PET) and contrast-enhanced computed tomography (CT) were performed using a hybrid PET/CT system in a patient with recurrent GBM before and after LITT. …”
    Get full text
    Article
  16. 76

    False Positive 18F-FDG Uptake in Mediastinal Lymph Nodes Detected with Positron Emission Tomography in Breast Cancer: A Case Report by Gamze Uğurluer, Mustafa Kibar, Sinan Yavuz, Akin Kuzucu, Meltem Serin

    Published 2013-01-01
    “…Accurate staging is important in determining prognosis and appropriate treatment. Positron emission tomography with computed tomography detects malignancies using 2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG PET CT) with high accuracy and they contribute to decisions regarding diagnosis, staging, recurrence, and treatment response. …”
    Get full text
    Article
  17. 77

    18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Accuracy in the Staging of Non-Small Cell Lung Cancer: Review and Cost-Effectiveness by Nieves Gómez León, Sofía Escalona, Beatriz Bandrés, Cristobal Belda, Daniel Callejo, Juan Antonio Blasco

    Published 2014-01-01
    “…Disease stage was confirmed based on histology results, which were compared with those of PET/CT and positron emission tomography (PET) and computed tomography (CT) separately. 63 patients classified with ≥IIIA disease stage by PET/CT did not undergo surgery. …”
    Get full text
    Article
  18. 78
  19. 79

    [F]Fluoroethyltyrosine–Positron Emission Tomography-Based Therapy Monitoring after Stereotactic Iodine-125 Brachytherapy in Patients with Recurrent High-Grade Glioma by Nathalie L. Jansen, Bogdana Suchorska, Silke B. Schwarz, Sabina Eigenbrod, Juergen Lutz, Vera Graute, Peter Bartenstein, Claus Belka, Friedrich W. Kreth, Christian la Fougère

    Published 2013-05-01
    “…We evaluated the prognostic value of serial [ 18 F]fluoroethyltyrosine (FET)-positron emission tomographic (PET) scans for therapy monitoring of high-grade glioma (HGG) after SBT. …”
    Get full text
    Article
  20. 80